Calanolide looks promising.
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D017322:Clinical Trials, Phase II as Topic; D003374:Coumarins / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008296:Malaysia; D011379:Prognosis; D039681:Pyranocoumarins; D012680:Sensitivity and Specificity; D012846:Singapore; D014481:United States
D019380:Anti-HIV Agents; D003374:Coumarins; D039681:Pyranocoumarins; C075959:calanolide A